Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls

Yersinia are common contaminants of food products, but their prevalence in the human gut is poorly documented. Yersinia have been implicated in Crohn's Disease (CD, an inflammatory bowel disease) however their role in CD is controversial. We performed highly sensitive PCR assays of specific seq...

Full description

Bibliographic Details
Main Authors: Guillaume Le Baut, Claire O'Brien, Paul Pavli, Maryline Roy, Philippe Seksik, Xavier Tréton, Stéphane Nancey, Nicolas Barnich, Madeleine Bezault, Claire Auzolle, Dominique Cazals-Hatem, Jérome Viala, Matthieu Allez, The REMIND GROUP, Jean-Pierre Hugot, Anne Dumay
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2018.00336/full
id doaj-68b31fa2f650458c8f1bfcb6a70a9f15
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Guillaume Le Baut
Guillaume Le Baut
Claire O'Brien
Claire O'Brien
Paul Pavli
Paul Pavli
Maryline Roy
Philippe Seksik
Xavier Tréton
Xavier Tréton
Stéphane Nancey
Stéphane Nancey
Nicolas Barnich
Madeleine Bezault
Claire Auzolle
Dominique Cazals-Hatem
Dominique Cazals-Hatem
Jérome Viala
Jérome Viala
Matthieu Allez
The REMIND GROUP
Jean-Pierre Hugot
Jean-Pierre Hugot
Anne Dumay
spellingShingle Guillaume Le Baut
Guillaume Le Baut
Claire O'Brien
Claire O'Brien
Paul Pavli
Paul Pavli
Maryline Roy
Philippe Seksik
Xavier Tréton
Xavier Tréton
Stéphane Nancey
Stéphane Nancey
Nicolas Barnich
Madeleine Bezault
Claire Auzolle
Dominique Cazals-Hatem
Dominique Cazals-Hatem
Jérome Viala
Jérome Viala
Matthieu Allez
The REMIND GROUP
Jean-Pierre Hugot
Jean-Pierre Hugot
Anne Dumay
Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
Frontiers in Cellular and Infection Microbiology
yersinia
Crohn's disease
gut microbiota
ileal mucosa
innate immunity
mucosal immune system
author_facet Guillaume Le Baut
Guillaume Le Baut
Claire O'Brien
Claire O'Brien
Paul Pavli
Paul Pavli
Maryline Roy
Philippe Seksik
Xavier Tréton
Xavier Tréton
Stéphane Nancey
Stéphane Nancey
Nicolas Barnich
Madeleine Bezault
Claire Auzolle
Dominique Cazals-Hatem
Dominique Cazals-Hatem
Jérome Viala
Jérome Viala
Matthieu Allez
The REMIND GROUP
Jean-Pierre Hugot
Jean-Pierre Hugot
Anne Dumay
author_sort Guillaume Le Baut
title Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
title_short Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
title_full Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
title_fullStr Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
title_full_unstemmed Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
title_sort prevalence of yersinia species in the ileum of crohn's disease patients and controls
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2018-09-01
description Yersinia are common contaminants of food products, but their prevalence in the human gut is poorly documented. Yersinia have been implicated in Crohn's Disease (CD, an inflammatory bowel disease) however their role in CD is controversial. We performed highly sensitive PCR assays of specific sequences for the gyrB gene of Y. aldovae, Y. bercovieri, Y. enterocolitica, Y. intermedia, Y. mollaretii and the inv gene of Y. pseudotuberculosis. We analyzed a total of 470 ileal samples taken from 338 participants (262 CD patients and 76 controls) belonging to three independent cohorts. All patients and controls were phenotyped and genotyped for the main CD susceptibility variants: NOD2, ATG16L1, and IRGM. Yersinia were found in 7.7% of ileal samples (respectively 7.9 and 7.6% in controls and CD patients) corresponding to 10% of participants (respectively 11.8 and 9.5% in controls and CD patients). Y. enterocolitica, Y. pseudotuberculosis and Y. intermedia were the most frequently identified species. The bacteria were more frequent in resected specimens, lymph nodes and Peyer's patches. Yersinia were no more likely to be detected in CD tissues than tissues from inflammatory and non-inflammatory controls. CD patients treated with immunosuppressants were less likely to be Yersinia carriers. In conclusion, this work shows that Yersinia species are frequently found at low levels in the human ileum in health and disease. The role of Yersinia species in this ecosystem should now be explored.
topic yersinia
Crohn's disease
gut microbiota
ileal mucosa
innate immunity
mucosal immune system
url https://www.frontiersin.org/article/10.3389/fcimb.2018.00336/full
work_keys_str_mv AT guillaumelebaut prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT guillaumelebaut prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT claireobrien prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT claireobrien prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT paulpavli prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT paulpavli prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT marylineroy prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT philippeseksik prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT xaviertreton prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT xaviertreton prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT stephanenancey prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT stephanenancey prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT nicolasbarnich prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT madeleinebezault prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT claireauzolle prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT dominiquecazalshatem prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT dominiquecazalshatem prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT jeromeviala prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT jeromeviala prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT matthieuallez prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT theremindgroup prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT jeanpierrehugot prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT jeanpierrehugot prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
AT annedumay prevalenceofyersiniaspeciesintheileumofcrohnsdiseasepatientsandcontrols
_version_ 1725828800268206080
spelling doaj-68b31fa2f650458c8f1bfcb6a70a9f152020-11-24T22:04:47ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882018-09-01810.3389/fcimb.2018.00336413785Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and ControlsGuillaume Le Baut0Guillaume Le Baut1Claire O'Brien2Claire O'Brien3Paul Pavli4Paul Pavli5Maryline Roy6Philippe Seksik7Xavier Tréton8Xavier Tréton9Stéphane Nancey10Stéphane Nancey11Nicolas Barnich12Madeleine Bezault13Claire Auzolle14Dominique Cazals-Hatem15Dominique Cazals-Hatem16Jérome Viala17Jérome Viala18Matthieu Allez19The REMIND GROUPJean-Pierre Hugot20Jean-Pierre Hugot21Anne Dumay22UMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, FranceDepartment of Gastroenterology and Nutrition, Centre Hospitalier Universitaire de Caen, Caen, FranceIBD Research Group, Canberra Hospital, Canberra, ACT, AustraliaAustralian National University Medical School, Canberra, ACT, AustraliaIBD Research Group, Canberra Hospital, Canberra, ACT, AustraliaAustralian National University Medical School, Canberra, ACT, AustraliaUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, FranceGastroenterology Unit, CNRS, INSERM, ERL 1157, LBM, APHP, Saint Antoine Hospital, Sorbonne Universités, UPMC Univ Paris 06, Ecole Normale Superieure, Paris, FranceUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, FranceDepartments of Gastroenterology and Pathology, Hôpital Beaujon, Assistance Publique Hopitaux de Paris, Paris, FranceDepartment of Gastroenterology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, FranceINSERM U1111, International Center for Research in Infectiology, Lyon, FranceUMR 1071 Inserm/Université d'Auvergne, USC-INRA 2018, Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte (M2iSH), CRNH Auvergne, Clermont-Ferrand, France0Department of Gastroenterology, Saint-Louis Hospital, APHP, INSERM U1160, University Denis Diderot, Paris, France0Department of Gastroenterology, Saint-Louis Hospital, APHP, INSERM U1160, University Denis Diderot, Paris, FranceUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, FranceDepartments of Gastroenterology and Pathology, Hôpital Beaujon, Assistance Publique Hopitaux de Paris, Paris, FranceUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, France1Department of Pediatric Gastroenterology, Hôpital Robert Debré, Assistance-Publique Hôpitaux de Paris, Paris, France0Department of Gastroenterology, Saint-Louis Hospital, APHP, INSERM U1160, University Denis Diderot, Paris, FranceUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, France1Department of Pediatric Gastroenterology, Hôpital Robert Debré, Assistance-Publique Hôpitaux de Paris, Paris, FranceUMR1149 INSERM, Research Centre on Inflammation, Université Paris Diderot-Sorbonne Paris-Cité, Paris, FranceYersinia are common contaminants of food products, but their prevalence in the human gut is poorly documented. Yersinia have been implicated in Crohn's Disease (CD, an inflammatory bowel disease) however their role in CD is controversial. We performed highly sensitive PCR assays of specific sequences for the gyrB gene of Y. aldovae, Y. bercovieri, Y. enterocolitica, Y. intermedia, Y. mollaretii and the inv gene of Y. pseudotuberculosis. We analyzed a total of 470 ileal samples taken from 338 participants (262 CD patients and 76 controls) belonging to three independent cohorts. All patients and controls were phenotyped and genotyped for the main CD susceptibility variants: NOD2, ATG16L1, and IRGM. Yersinia were found in 7.7% of ileal samples (respectively 7.9 and 7.6% in controls and CD patients) corresponding to 10% of participants (respectively 11.8 and 9.5% in controls and CD patients). Y. enterocolitica, Y. pseudotuberculosis and Y. intermedia were the most frequently identified species. The bacteria were more frequent in resected specimens, lymph nodes and Peyer's patches. Yersinia were no more likely to be detected in CD tissues than tissues from inflammatory and non-inflammatory controls. CD patients treated with immunosuppressants were less likely to be Yersinia carriers. In conclusion, this work shows that Yersinia species are frequently found at low levels in the human ileum in health and disease. The role of Yersinia species in this ecosystem should now be explored.https://www.frontiersin.org/article/10.3389/fcimb.2018.00336/fullyersiniaCrohn's diseasegut microbiotaileal mucosainnate immunitymucosal immune system